Scientists at DKFZ and SickKids found that certain antibodies can cooperate with each other to bind stronger to malaria parasites, improving the immune response. This discovery could lead to the development of more effective vaccines against malaria.
Researchers have discovered universal antibodies that can recognize and neutralize a wide range of microorganisms, including bacteria, yeasts, and viruses. These breakthrough findings hold promise for developing new treatments for life-threatening infections, particularly in patients with weakened immune systems.
Researchers have developed criteria for routine genetic screening of patients with medulloblastoma, a rare and malignant tumor predominantly affecting children. This analysis of 1022 patients identified six genes frequently affected by genetic alterations, increasing cancer risk in up to 20% of the patient population.
A large study of breast cancer patients found that radiotherapy and chemotherapy do not significantly increase the risk of heart disease. Good risk management in hospitals and short interval screenings may offset elevated risks. The study's findings are considered positive for treatment of breast cancer.
Researchers found that elevated methylglyoxal levels lead to insulin resistance, obesity, and high blood sugar levels in flies, challenging the conventional view of type 2 diabetes. This discovery raises questions about the molecular causes of the disease.
Researchers from DKFZ found that circulating cancer cells exhibit specific polarity, which helps them attach to endothelial cells and migrate into tissues. This discovery may help predict individual risk for metastasis and find therapies to reduce it.
A combined analysis of family history and genetic markers improves risk prediction for colorectal cancer, revealing that individuals with a positive family history and numerous genetic variants are at increased risk. This approach can help adjust preventive measures and screening schedules.
Researchers developed a method combining diffusion-weighted MRI with intelligent image analysis to detect malignant changes in breast tissue. The new method reduced false positive findings by 70% and accurately identified malignant tumors in 98% of cases.
The marbled crayfish, a single female ancestor of all Marmorkrebs specimens, exhibits epigenetic mechanisms that enable rapid adaptation to various environments without genetic variation. This clonal genome evolution shares similarities with tumor development, where environmental factors influence gene regulation and adaptation.
Scientists at German Cancer Research Center have discovered a new target for anti-angiogenic tumor therapy by deleting a signaling molecule in mice, leading to delayed tumor growth and limited metastases. The receptor Tie1 plays a crucial role in angiogenesis and is overexpressed in tumors.
Researchers discovered that a shift from fatty acid to carbohydrate-based energy sources can lead to congestive heart failure. The study identified Notch-1 receptor as key player controlling transport of fatty acids into cardiac muscle tissue.
A gene enhancer cluster, BENC, plays a crucial role in regulating Myc activity and cancer growth. The discovery suggests BENC as a potential target for novel therapies against blood cancer.
A team of scientists has identified molecular super enhancers that regulate tumor development in ependymoma, a common type of brain cancer in children. By targeting these enhancers, researchers have shown promise in slowing down or stopping the growth of ependymoma cells.
Researchers at German Cancer Research Center prove grid cells measure distances and enable path integration in mice, aiding spatial orientation. This innate behavior helps animals find the most direct route from A to C without learning or visual cues.
Kinase inhibitors show promise in treating various types of blood and lung cancers by blocking overactive enzymes that control cell growth. Researchers identified new target structures for drugs, including the kinase MELK, which is linked to poor prognosis in lung cancer.
Researchers at the German Cancer Research Center have found that papillomaviruses associated with UV light can promote the development of non-melanoma skin cancer. The viruses affect the stability of host cell DNA, leading to accumulation of UV-related damage. This link has been previously underinvestigated in human biopsies.
Researchers at the German Cancer Research Center found that natural infection with malaria induces a strong immune response, producing antibodies that protect mice from infection. The study's findings will help develop more effective and specific vaccines against the disease.
Researchers at German Cancer Research Center discovered a link between energy metabolism and epigenetic code in leukemias and brain cancer. The enzyme BCAT1 plays a key role in the development of malignant tumors, including acute myeloid leukemia and breast cancer.
Researchers have developed a new leukemia therapy that combines inhibitors with immune therapies to eliminate cancer cells, showing promising results in preclinical trials. The combination of treatments worked better than using one active substance alone.
A recent study found that chronic cell death promotes the development of liver cancer by causing remaining cells to divide at higher rates. The researchers also identified caspase 8 as an enzyme playing a dual role in this process, involving both apoptosis and DNA repair.
Researchers at the German Cancer Research Center create a new barcode system to study blood cell development, revealing two major branches that give rise to different cell types. The technology allows for precise tracking of individual cells and has implications for cancer research and other tissue studies.
Cancer cells use exosomes and semiochemicals to suppress the immune response, allowing them to multiply unopposed. Researchers have identified multiple new therapy approaches, including inhibiting PD-L1 receptors and blocking the recognition of Y RNA messages.
Researchers have identified a wide genetic variety in medulloblastoma, the most common type of childhood brain cancer. This discovery could lead to more precise subgroups and individualized treatments, improving curative chances and reducing side effects.
Researchers have found that the Tie2 receptor on pericytes plays a crucial role in regulating blood vessel growth and maturation. By breeding mice with disabled Tie2 receptors, scientists discovered that tumor blood vessels grew faster and more aggressively without this control, highlighting potential new targets for cancer therapy.
Scientists have successfully employed a novel type of imaging that uses glucose metabolism activity to identify solid tumors or aggressively growing areas. This method, called magnetization transfer effect, allows for the visualization of changes in glucose levels in brain tissue without the need for radioactivity.
Researchers identified a key signaling pathway causing bile duct cancer and found possibilities to interrupt it. High ROS levels and TNF production promote tumor growth, but antioxidants and JNK inhibitors can stop tumorigenesis.
Researchers at German Cancer Research Center (DKFZ) have discovered mysterious gene transcripts that arise in treated cancer cells. These transcripts, originating from ancient viral elements, may be used as biomarkers to monitor the effectiveness of epigenetic therapy.
Researchers at German Cancer Research Center (DKFZ) found a substance that blocks cancer-promoting metabolic products in leukemia and brain tumors. The investigational compound BAY1436032 is effective against AML and glioblastomas, reducing stem-cell properties and tumor cell growth.
Research by the German Cancer Research Center has found that defective intercellular connections in the ependyma, a cellular layer separating the brain nervous tissue from CSF, cause hydrocephalus. This leads to blockage of the aqueduct, blocking cerebrospinal fluid flow and resulting in swollen heads and brain pressure.
Research by the German Cancer Research Center found that vitamin A deficiency can lead to a loss of dormant stem cells in the bone marrow, impairing the immune system. The study suggests that understanding how vitamin A regulates these stem cells could lead to new cancer treatments.
Researchers have discovered a key peptide called DBI that promotes the production of new neurons in the hippocampus, a region critical for learning and memory. DBI binds to GABA receptors, suppressing its inhibitory effect and allowing neural stem cells to proliferate.
Researchers have developed a biomarker that can detect early signs of HPV16 E6 antibody presence in blood samples, indicating high risk of developing oropharyngeal cancer. The test is highly specific but not suitable for larger population groups due to low new case incidence rates.
Researchers have developed an effective antibody against radiation-induced pulmonary fibrosis, a debilitating side effect of lung cancer treatment. The antibody targets connective tissue growth factor (CTGF), reversing fibrotic transformation and improving pulmonary function in mice.
Researchers analyzed DNA methylation levels in 1,900 participants to identify 58 CpGs linked to mortality. These epigenetic marks show stronger correlations with survival than previously studied genetic alterations.
Researchers found high levels of activated Notch in tumor endothelium, promoting cancer cell invasion into bloodstream and forming lung metastases. Blocking Notch with antibodies reduced metastasis and immune cell invasion.
Scientists have identified a new mechanism by which the Epstein-Barr virus (EBV) causes cancer, involving a viral protein that leads to chromosomal instability. The discovery has significant implications for vaccine development and cancer prevention.
Researchers identified dopamine receptor DRD2 as a key molecule in pancreatic cancer. Blocking the receptor inhibited cancer growth, while its blockade also slowed tumor growth in mice.
A new mutation in the ZBTB7A gene boosts energy metabolism in leukemia cells, promoting their growth and survival. This discovery offers a promising therapeutic target for treating acute myeloid leukemia (AML) patients.
Researchers discovered that pancreatic cancers acquire metastatic capacity before transforming into cancer cells. Low miR-192 levels in tumor tissue are associated with rapidly progressing disease. miR-192 may serve as a clinical marker and potential therapeutic target for pancreatic cancer treatment.
Scientists have developed new methods to monitor endogenous oxidants, which are essential chemical messengers that help maintain organism function. The methods involve genetically encoded probes that can detect specific oxidants in real-time and down to single-cell levels.
Scientists have discovered that deactivating the MYC oncogene can induce a dormant state in embryonic stem cells, similar to diapause, allowing them to survive without growth or metabolism. This finding has implications for controlling cancer stem cells and metastasis.
Researchers found that DNA methylation patterns in leukemia cells can vary significantly across different cell maturation stages. However, the 'cancer-typical' methyl patterns discovered so far are actually indicative of the normal development process rather than cancer-specific changes.
A gold standard data record has been established to improve cancer genome analysis and detect somatic mutations reliably. The record, obtained from interlaboratory testing, provides a basis for laboratories to evaluate their bioinformatic methods and thresholds for detecting specific mutations.
Scientists have discovered a surprising role of Wnt signaling in controlling male fertility. The research found that Wnt protects proteins from degradation, allowing sperm to mature and move forward. This discovery has potential implications for the treatment of infertility and contraception.
Researchers discovered brain cancer cells form a complex network to resist treatment and invade healthy brain tissue. The tumor cells use this network to communicate and repair damage, making it resistant to radiation therapy.
Researchers at German Cancer Research Center find that freshwater marbled crayfish exhibit parthenogenesis, a process where animals reproduce without fertilization, and use this as an ideal model for studying epigenetics in cancer. The discovery could lead to new insights into the development of the disease.
Researchers found that a tolerant immune system, characterized by high levels of regulatory T cells, increases the risk of certain types of cancer. The study analyzed blood samples from EPIC participants with cancer and controls, revealing a strong link between immunotolerance and increased lung and colon cancer risks.
Researchers discovered that Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells, making it a promising therapeutic target for cancer treatment and eye diseases.
A study by German Cancer Research Center discovered that citric acid from lemon juice can alter the morphology of norovirus particles, reducing their infectivity. The researchers found that citrate binds to specific proteins on the virus, preventing it from attaching to host cells.
Researchers at DKFZ found a new control mechanism that regulates mitochondrial fusion and fragmentation, improving energy production. Adding stearic acid to fly food enhanced mitochondrial performance, suggesting potential therapeutic applications for mitochondrial diseases.